Floatz logo

Plavix

G6PD Deficiency

First Affiliated Hospital, Sun Yat-Sen UniversityPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the G6PD Deficiency cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
First Affiliated Hospital, Sun Yat-Sen University
Phase 4BB
Tin Mesoporphyrin
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase 2NR

Same molecule, other indications

Plavix is also rated in:

myocardial infarctionDormant
A
Indicative ·
81 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
77 / 100
View asset →
peripheral arterial diseaseDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →